Kenya Asthma Drug Market Growing Trade Among Emerging Economies Opening New Opportunities (2023-2028)

The Kenya Asthma Drug Market 2023 Report makes available the current and forthcoming technical and financial details of the industry. It is one of the most comprehensive and important additions to the Prudent Markets archive of market research studies. It offers detailed research and analysis of key aspects of the global Kenya Asthma Drug market. This report explores all the key factors affecting the growth of the global Kenya Asthma Drug market, including demand-supply scenario, pricing structure, profit margins, production, and value chain analysis.

Get PDF Sample Report Now! @ https://www.prudentmarkets.com/sample-request/141657/

Report Overview

The Asthma drugs market size in Kenya stood at USD xx billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period

Asthma is a chronic respiratory disease affecting children and adults. The air passages in the lungs become narrow due to inflammation and tightening of the muscles around the small airways. Common symptoms include cough, wheeze, shortness of breath and chest tightness. These symptoms are intermittent and are often worse at night or during exercise. In Kenya, asthma is more common in urban settlements than in rural areas. This may be attributed to extensive use of wood and charcoal for cooking in Kenyan households, increase in outdoor pollution due to rapid urbanization and smoking. According to a study conducted in 2018, to determine prevalence and risk factors in Kenya found that the prevalence of asthma ranged from 3% to 28.6%.

Market Drivers

The market is majorly driven by the rise in the prevalence of Asthma in Kenya. According to the Global Asthma Report 2018, Asthma in children in Kenya remains a challenging issue. Based on results of International Study of Asthma and Allergies in Childhood (ISAAC), there was an increase in the prevalence of asthma symptoms in 13-14 years aged children from 17.1% to 18% in Nairobi.

Rise in the prevalence of asthma in Kenya may be attributed to a surge in smoking among adolescents, increase in the outdoor pollution due to rapid urbanization as well as indoor pollution due to the extensive use of wood and charcoal for cooking in Kenyan households.

There is uncontrolled or unregulated exposure to many irritant pollutants such as dust, smoke and pesticides. The risk and intensity of exposure to these harmful irritants amongst different vulnerable groups continues to increase due to the lack of clear regulatory policies particularly in informal occupational settings. The market is also driven by the presence of strong and robust pipeline drugs in the Asthma drug market.

However, some of the side effects of the oral drugs widely used in Kenya are tremors and palpitations. This is one of the restraining factors for growth in the asthma drug market.

To Know More About COVID-19 Impact On Kenya Asthma Drug Market @ https://www.prudentmarkets.com/sample-request/141657/

Market Segmentation

By Drug Class:

On the basis of drug class, the asthma drug market in Kenya can be segmented into Bronchodilators, Leukotriene Antagonists, Mast Cell Stabilizers, Corticosteroids, and Monoclonal Antibodies.

Bronchodilators can be further segmented into short acting and long-acting beta 2 agonists. The rapid and short acting beta 2 agonists include salbutamol, fenoterol, terbutaline, pirbuterol and procaterol. Salmetrol and Formoterol are long-acting beta 2 agonists with prolonged bronchodilator action that lasts up to 12 hours.

 By Route of Administration:

On the basis of route of administration, the asthma drug market can be segmented into oral drugs, inhalation drugs and parenteral route.

The inhaler segment includes dry powder, metered dose, and soft mist inhalers. The metered-dose inhalers (MDIs) segment dominates the market. This is majorly attributed to reliability, versatility, self-containment, easy availability, portability, and cost-efficient medical aerosol delivery option among others.

By Distribution Channel:

On the basis of distribution channel, the market for Asthma drugs can be segmented into hospital pharmacies, retail pharmacies, online pharmacies, and others.

The retail pharmacies segment will dominate the market throughout the forecast period.

Major Players

Top drug makers are making sizeable investments in clinical trials focused on reducing asthma exacerbations, in a move to develop advanced and more efficacious drugs for managing asthma. Players holding prominent position in Kenya in the preventive asthma drug market include Abbott Laboratories, F. Hoffmann-La Roche, Merck & Co., AstraZeneca, Cipla, GlaxoSmithKline, and Novartis AG.

Cipla is leading in the Asthma Drug market with its products like Asthalin, Budecort, Aerocort, and Duolin etc.

Prudent Markets provides attractive discounts that fit your needs. Customization of the reports as per your requirement is also offered. Get in touch with our sales team, who will guarantee you a report that suits your needs.

Speak To Our Analyst For A Discussion On The Above Findings, And Ask For A Discount On The Report @ https://www.prudentmarkets.com/discount-request/141657/

The report covers the competitive analysis of the market. As the demand is driven by a buyer's paying capacity and the rate of item development, the report shows the important regions that will direct growth. This section exclusively shares insight into the budget reports of big-league members of the market helping key players and new entrants understand the potential of investments in the Global Kenya Asthma Drug Market. It can be better employed by both traditional and new players in the industry for complete know-how of the market.

Strategic Points Covered in Table of Content of Global Kenya Asthma Drug Market:

Chapter 1: Introduction, market driving force product Objective of Study and Research Scope the Kenya Asthma Drug market
Chapter 2: Exclusive Summary - the basic information of the Kenya Asthma Drug Market.
Chapter 3: Displaying the Market Dynamics- Drivers, Trends and Challenges & Opportunities of the Kenya Asthma Drug
Chapter 4: Presenting the Kenya Asthma Drug Market Factor Analysis, Porters Five Forces, Supply/Value Chain, PESTEL analysis, Market Entropy, Patent/Trademark Analysis.
Chapter 5: Displaying the by Type, End User and Region/Country
Chapter 6: Evaluating the leading manufacturers of the Kenya Asthma Drug market which consists of its Competitive Landscape, Peer Group Analysis, BCG Matrix & Company Profile
Chapter 7: To evaluate the market by segments, by countries and by Manufacturers/Company with revenue share and sales by key countries in these various regions
Chapter 8 & 9: Displaying the Appendix, Methodology and Data Source

Any Questions? Feel Free To Enquire Here. We Will put you on the Right Path @ https://www.prudentmarkets.com/enquiry-request/141657/

Free Customization on the basis of client requirements on Immediate purchase:
1- Free country-level breakdown of any 5 countries of your interest.
2- Competitive breakdown of segment revenue by market players.

Customization of the Report:
This report can be customized to meet the client's requirements. Please connect with our sales team (sales@prudentmarkets.com), who will ensure that you get a report that suits your needs. You can also get in touch with our executives on +91 83560 50278 || USA/Canada(Toll Free): 1800-601-6071 to share your research requirements.

Get ready to Recognize the pros and cons of the regulatory framework, local reforms, and its effect on the Industry. Understand how the Leaders in Intelligent Network are keeping themselves one stage forward with our most up-to-date survey analysis.

In conclusion, the Kenya Asthma Drug Market report is a genuine source for accessing the research data which is projected to exponentially grow your business. The report provides information such as economic scenarios, benefits, limits, trends, market growth rates, and figures. SWOT analysis and PESTLE analysis is also incorporated in the report.

Contact Us:
Allan Carter
Andheri, Maharashtra, 400102
USA/Canada(Toll Free): 1800-601-6071
Direct Line: +91 83560 50278
Mail: sales@prudentmarkets.com
Web: www.prudentmarkets.com

About Us:
We are leaders in market analytics, business research, and consulting services for Fortune 500 companies, start-ups, financial & government institutions. Since we understand the criticality of data and insights, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available. To be at our client's disposal whenever they need help on market research and consulting services. We also aim to be their business partners when it comes to making critical business decisions around new market entry, M&A, competitive Intelligence and strategy.

This release was published on openPR.